Editor LSA

Penny Stock Runners - Federal National Mortgage Association(OTCBB:FNMA), NanoViricides Inc(OTCBB:NNVCD), Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY), Exide Technologies(OTCMKTS:XIDEQ)

 

Lewes, DE -- (SBWIRE) -- 09/19/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Federal National Mortgage Association(OTCBB:FNMA), NanoViricides Inc(OTCBB:NNVCD), Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY), Exide Technologies(OTCMKTS:XIDEQ).

Federal National Mortgage Association(OTCBB:FNMA) ended lower -0.85% and complete the day at $1.17. The total number of shares changed hands during the day was 5.46 million. After opening at $1.17, the stock hit as high as $1.18. However, it traded between $0.25 and $5.44 over the last twelve months.

Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States. The company securitizes mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities

Has FNMA Found The Bottom and Ready To Move Up? Find Out Here

NanoViricides Inc(OTCBB:NNVCD) closed yesterday at $5.43, a +18.04% increase. Around 560,800 shares were traded, beating an-average trading volume of 221,502 shares. The company is now valued at around $255.27 million.

NanoViricides, Inc., a nano-biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of viral infections

For How Long NNVCD Gloss will Attract Investors? Find out via this report

Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY) moved +3.43 percent higher at $65.77 and traded between $63.60 and 65.80 after opening the day at $63.67. Its performance over the last five days remained 5%, which stands at 2.8% for a month. Going back further than one month, 1-year performance after recent close was 30.26%.

Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, prevention, diagnosis, treatment, and treatment monitoring of diseases.

For How Long RHHBY Gloss will Attract Investors? Find out via this report

Exide Technologies(OTCMKTS:XIDEQ) shares rose, gaining +15.25 percent to close at $0.461. The stock is down around -86.32% this year and -85.5% for the last 12 months. Around 5.10 million shares changed hands yesterday, higher from an-average trading volume of 1.34 million shares.

Exide Technologies manufactures and supplies lead-acid batteries for transportation and industrial applications worldwide. The company operates in four segments: Transportation Americas, Transportation Europe and Rest of World (ROW), Industrial Energy Americas, and Industrial Energy Europe and ROW

Why Should Investors Buy XIDEQ After The Recent Gain? Just Go Here and Find Out

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/